Cancer Incidence and Risk Factors Among Immunocompromised Patients
The cancer incidence in certain immunocompromised patients was almost twice as high as the age-adjusted cancer incidence in the general population.
The cancer incidence in certain immunocompromised patients was almost twice as high as the age-adjusted cancer incidence in the general population.
There was no significant difference in post-infusion hospitalizations between patients with and without a history of cancer.
Patients with perineural invasion had a 4-fold higher risk of biochemical recurrence.
The Infectious Diseases Society of America and the American Society of Microbiology formed a committee to review the potential effect of SARS-CoV-2 genotyping in clinical care settings.
Researchers conducted a study to assess whether an at-home neutralizing monoclonal antibody infusion program decreases the risk for hospitalization among patients with SARS-CoV-2 infection at increased risk for progression to severe disease.
Researchers aimed to simplify the process of identifying patients with atherosclerotic cardiovascular disease (ASCVD) at very high risk for future events.
Researchers sought to evaluate the efficacy and safety of teprasiran for reducing acute kidney injury after cardiac surgery in patients at high risk.
In this fifth update to the living guidelines on drugs for the treatment of COVID-19, the World Health Organization analyzed results of clinical trials that assessed the effects of casirivimab-imdevimab and corticosteroids in patients with severe and non-severe disease.
Chronic kidney disease increases the risk of cardiovascular events associated with type 2 diabetes. A clinical trial sought to discover if finerenone would help patients with both of these conditions.
Investigators report findings from the Dapagliflozin and Prevention of Adverse outcomes in CKD (DAPA-CKD) study.